Max Planck Publications of Herwig Lab
The following publications were published exclusively under the affiliation of the Max Planck Society. For publications by the principal investigator outside of the Max Planck Society, see the links on the lower left.
Journal Article (8)
Journal Article
31 (23), pp. 4019 - 4033 (2022)
Comparative genomic analyses of multiple backcross mouse populations suggest SGCG as a novel potential obesity-modifier gene. Human Molecular Genetics
Journal Article
140 (20), pp. 2113 - 2126 (2022)
Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies. Blood
Journal Article
9 (1), 699 (2022)
Multi-omics HeCaToS dataset of repeated dose toxicity for cardiotoxic & hepatotoxic compounds. Scientific Data
Journal Article
14 (16), 3950 (2022)
Pre-Training on In Vitro and Fine-Tuning on Patient-Derived Data Improves Deep Neural Networks for Anti-Cancer Drug-Sensitivity Prediction. Cancers / Molecular Diversity Preservation International (MDPI)
Journal Article
3 (2), 101353 (2022)
Gradient tree boosting and network propagation for the identification of pan-cancer survival networks. STAR Protocols
Journal Article
27 (6), 173 (2022)
Epirubicin Alters DNA Methylation Profiles Related to Cardiotoxicity. Frontiers in Bioscience-Landmark
Journal Article
4 (1), lqab128 (2022)
Matching anticancer compounds and tumor cell lines by neural networks with ranking loss. NAR: genomics and bioinformatics
Journal Article
50 (D1), pp. D587 - D595 (2022)
ConsensusPathDB 2022: molecular interactions update as a resource for network biology. Nucleic Acids Research Book Chapter (1)
Book Chapter
2590, pp. 237 - 272 (Eds. Peters, B. A.; Drmanac, R.). Humana Press (Springer Science+Business Media, Springer-Verlag GmbH), New York, NY (2022)
Analysis of 1276 Haplotype-Resolved Genomes Allows Characterization of Cis- and Trans-Abundant Genes. In: Haplotyping. Methods in Molecular Biology (Springer Protocols), Vol.